The AcT Trial: Tenecteplase vs Alteplase for Acute Ischemic Stroke
RebelEM
FEBRUARY 1, 2024
Tenecteplase, a modified version of alteplase, is being increasingly utilized for AIS due to its favorable pharmacological profile, ease of administration, and cost effectiveness. Reliance on research coordinators to accurately determine mRS scores over a telephone interview could suffer from issues of reliability. vs Alteplase 34.8%
Let's personalize your content